Phosphodiesterase 4 inhibitors and drugs of abuse: current knowledge and therapeutic opportunities
Christopher M. Olsen, Qing-Song Liu
Phosphodiesterase 4 inhibitors and drugs of abuse: current knowledge and therapeutic opportunities
BACKGROUND: Long-term exposure to drugs of abuse causes an upregulation of the cAMP-signaling pathway in the nucleus accumbens and other forebrain regions, this common neuroadaptation is thought to underlie aspects of drug tolerance and dependence. Phosphodiesterase 4 (PDE4) is an enzyme that the selective hydrolyzes intracellular cAMP. It is expressed in several brain regions that regulate the reinforcing effects of drugs of abuse.
OBJECTIVE: Here, we review the current knowledge about central nervous system (CNS) distribution of PDE4 isoforms and the effects of systemic and brain-region specific inhibition of PDE4 on behavioral models of drug addiction.
METHODS: A systematic literature search was performed using the Pubmed.
RESULTS: Using behavioral sensitization, conditioned place preference and drug self-administration as behavioral models, a large number of studies have shown that local or systemic administration of PDE4 inhibitors reduce drug intake and/or drug seeking for psychostimulants, alcohol, and opioids in rats or mice.
CONCLUSIONS: Preclinical studies suggest that PDE4 could be a therapeutic target for several classes of substance use disorder. We conclude by identifying opportunities for the development of subtype-selective PDE4 inhibitors that may reduce addiction liability and minimize the side effects that limit the clinical potential of non-selective PDE4 inhibitors. Several PDE4 inhibitors have been clinically approved for other diseases. There is a promising possibility to repurpose these PDE4 inhibitors for the treatment of drug addiction as they are safe and well-tolerated in patients.
PDE4 / PDE4 inhibitors / VTA / nucleus accumbens / drug addiction
[1] |
Alberini C M (2009). Transcription factors in long-term memory and synaptic plasticity. Physiol Rev, 89(1): 121–145
CrossRef
Pubmed
Google scholar
|
[2] |
Allain F, Minogianis E A, Roberts D C, Samaha A N (2015). How fast and how often: The pharmacokinetics of drug use are decisive in addiction. Neurosci Biobehav Rev, 56: 166–179
CrossRef
Pubmed
Google scholar
|
[3] |
Anderson S M, Pierce R C (2005). Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement. Pharmacol Ther, 106(3): 389–403
CrossRef
Pubmed
Google scholar
|
[4] |
Bardo M T, Bevins R A (2000). Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology (Berl), 153(1): 31–43
CrossRef
Pubmed
Google scholar
|
[5] |
Beardsley P M, Hauser K F (2014). Glial modulators as potential treatments of psychostimulant abuse. Adv Pharmacol, 69: 1–69
CrossRef
Pubmed
Google scholar
|
[6] |
Beardsley P M, Shelton K L, Hendrick E, Johnson K W (2010). The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse. Eur J Pharmacol, 637(1-3): 102–108
CrossRef
Pubmed
Google scholar
|
[7] |
Bell R L, Lopez M F, Cui C, Egli M, Johnson K W, Franklin K M, Becker H C (2015). Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence. Addict Biol, 20(1): 38–42
CrossRef
Pubmed
Google scholar
|
[8] |
Bertolino A, Crippa D, di Dio S, Fichte K, Musmeci G, Porro V, Rapisarda V, Sastre-y-Hernández M, Schratzer M (1988). Rolipram versus imipramine in inpatients with major, “minor” or atypical depressive disorder: a double-blind double-dummy study aimed at testing a novel therapeutic approach. Int Clin Psychopharmacol, 3(3): 245–253
CrossRef
Pubmed
Google scholar
|
[9] |
Blednov Y A, Benavidez J M, Black M, Harris R A (2014). Inhibition of phosphodiesterase 4 reduces ethanol intake and preference in C57BL/6J mice. Front Neurosci, 8: 129
CrossRef
Pubmed
Google scholar
|
[10] |
Britt J P, Benaliouad F, McDevitt R A, Stuber G D, Wise R A, Bonci A (2012). Synaptic and behavioral profile of multiple glutamatergic inputs to the nucleus accumbens. Neuron, 76(4): 790–803
CrossRef
Pubmed
Google scholar
|
[11] |
Carlezon W A Jr, Chartoff E H (2007). Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc, 2(11): 2987–2995
CrossRef
Pubmed
Google scholar
|
[12] |
Cherry J A, Davis R L (1999). Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect. J Comp Neurol, 407(2): 287–301
CrossRef
Pubmed
Google scholar
|
[13] |
Conrad K L, Louderback K M, Milano E J, Winder D G (2013). Assessment of the impact of pattern of cocaine dosing schedule during conditioning and reconditioning on magnitude of cocaine CPP, extinction, and reinstatement. Psychopharmacology (Berl), 227(1): 109–116
CrossRef
Pubmed
Google scholar
|
[14] |
Conti M, Richter W, Mehats C, Livera G, Park J Y, Jin C (2003). Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J Biol Chem, 278(8): 5493–5496
CrossRef
Pubmed
Google scholar
|
[15] |
Crabbe J C (2014). Rodent models of genetic contributions to motivation to abuse alcohol. Nebr Symp Motiv, 61: 5–29
CrossRef
Pubmed
Google scholar
|
[16] |
Diamant Z, Spina D (2011). PDE4-inhibitors: a novel, targeted therapy for obstructive airways disease. Pulm Pharmacol Ther, 24(4): 353–360
CrossRef
Pubmed
Google scholar
|
[17] |
Fleischhacker W W H, Hinterhuber H, Bauer H, Pflug B, Berner P, Simhandl C, Wolf R, Gerlach W, Jaklitsch H, Sastre-y-Hernández M, Schmeding-Wiegel H, Sperner-Unterweger B, Voet B, Schubert H (1992). A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder. Neuropsychobiology, 26(1-2): 59–64
CrossRef
Pubmed
Google scholar
|
[18] |
Franklin K M, Hauser S R, Lasek A W, McClintick J, Ding Z M, McBride W J, Bell R L (2015). Reduction of alcohol drinking of alcohol-preferring (P) and high-alcohol drinking (HAD1) rats by targeting phosphodiesterase-4 (PDE4). Psychopharmacology (Berl), 232(13): 2251–2262
CrossRef
Pubmed
Google scholar
|
[19] |
Gisondi P, Girolomoni G (2016). Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis. Drug Des Devel Ther, 10: 1763–1770
CrossRef
Pubmed
Google scholar
|
[20] |
González-Cuello A, Sánchez L, Hernández J, Teresa Castells M, Victoria Milanés M, Laorden M L (2007). Phosphodiesterase 4 inhibitors, rolipram and diazepam block the adaptive changes observed during morphine withdrawal in the heart. Eur J Pharmacol, 570(1-3): 1–9
CrossRef
Pubmed
Google scholar
|
[21] |
Graybiel A M (1990). Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci, 13(7): 244–254
CrossRef
Pubmed
Google scholar
|
[22] |
Graybiel A M (2000). The basal ganglia. Curr Biol, 10(14): R509–R511
CrossRef
Pubmed
Google scholar
|
[23] |
Grimm J W, Fyall A M, Osincup D P (2005). Incubation of sucrose craving: effects of reduced training and sucrose pre-loading. Physiol Behav, 84(1): 73–79
CrossRef
Pubmed
Google scholar
|
[24] |
Grimm J W, Hope B T, Wise R A, Shaham Y (2001). Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature, 412(6843): 141–142
CrossRef
Pubmed
Google scholar
|
[25] |
Hagen T J, Mo X, Burgin A B, Fox D 3rd, Zhang Z, Gurney M E (2014). Discovery of triazines as selective PDE4B versus PDE4D inhibitors. Bioorg Med Chem Lett, 24(16): 4031–4034
CrossRef
Pubmed
Google scholar
|
[26] |
Hamdy M M, Mamiya T, Noda Y, Sayed M, Assi A A, Gomaa A, Yamada K, Nabeshima T (2001). A selective phosphodiesterase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice. Behav Brain Res, 118(1): 85–93
CrossRef
Pubmed
Google scholar
|
[27] |
Hansen R T 3rd, Zhang H T (2015). Phosphodiesterase-4 modulation as a potential therapeutic for cognitive loss in pathological and non-pathological aging: possibilities and pitfalls. Curr Pharm Des, 21(3): 291–302
Pubmed
|
[28] |
Hiroi N, Nestler E J (1998). Nuclear memory: gene transcription and behavior. Adv Pharmacol, 42: 1037–1041
CrossRef
Pubmed
Google scholar
|
[29] |
Horn C C, Kimball B A, Wang H, Kaus J, Dienel S, Nagy A, Gathright G R, Yates B J, Andrews P L (2013). Why can’t rodents vomit? A comparative behavioral, anatomical, and physiological study. PLoS ONE, 8(4): e60537
CrossRef
Pubmed
Google scholar
|
[30] |
Howlett, A. C. (2005). “Cannabinoid receptor signaling.” Handb Exp Pharmacol(168): 53–79.
|
[31] |
Hu W, Lu T, Chen A, Huang Y, Hansen R, Chandler L J, Zhang H T (2011). Inhibition of phosphodiesterase-4 decreases ethanol intake in mice. Psychopharmacology (Berl), 218(2): 331–339
CrossRef
Pubmed
Google scholar
|
[32] |
Ikemoto S, Bonci A (2014). Neurocircuitry of drug reward. Neuropharmacology, 76 Pt B: 329–341
|
[33] |
Itzhak Y, Anderson K L (2012). Changes in the magnitude of drug-unconditioned stimulus during conditioning modulate cocaine-induced place preference in mice. Addict Biol, 17(4): 706–716
CrossRef
Pubmed
Google scholar
|
[34] |
Iyo M, Bi Y, Hashimoto K, Inada T, Fukui S (1996). Prevention of methamphetamine-induced behavioral sensitization in rats by a cyclic AMP phosphodiesterase inhibitor, rolipram. Eur J Pharmacol, 312(2): 163–170
CrossRef
Pubmed
Google scholar
|
[35] |
Janes A C, Kantak K M, Cherry J A (2009). The involvement of type IV phosphodiesterases in cocaine-induced sensitization and subsequent pERK expression in the mouse nucleus accumbens. Psychopharmacology (Berl), 206(2): 177–185
CrossRef
Pubmed
Google scholar
|
[36] |
Johansson E M, Reyes-Irisarri E, Mengod G (2012). Comparison of cAMP-specific phosphodiesterase mRNAs distribution in mouse and rat brain. Neurosci Lett, 525(1): 1–6
CrossRef
Pubmed
Google scholar
|
[37] |
Kauer J A (2004). Learning mechanisms in addiction: synaptic plasticity in the ventral tegmental area as a result of exposure to drugs of abuse. Annu Rev Physiol, 66(1): 447–475
CrossRef
Pubmed
Google scholar
|
[38] |
Kimura M, Tokumura M, Itoh T, Inoue O, Abe K (2006). Lack of cyclic AMP-specific phosphodiesterase 4 activation during naloxone-precipitated morphine withdrawal in rats. Neurosci Lett, 404(1-2): 107–111
CrossRef
Pubmed
Google scholar
|
[39] |
Kimura S, Ohi Y, Haji A (2015). Blockade of phosphodiesterase 4 reverses morphine-induced ventilatory disturbance without loss of analgesia. Life Sci, 127: 32–38
CrossRef
Pubmed
Google scholar
|
[40] |
Knapp C M, Foye M M, Ciraulo D A, Kornetsky C (1999). The type IV phosphodiesterase inhibitors, Ro 20-1724 and rolipram, block the initiation of cocaine self-administration. Pharmacol Biochem Behav, 62(1): 151–158
CrossRef
Pubmed
Google scholar
|
[41] |
Knapp C M, Lee K, Foye M, Ciraulo D A, Kornetsky C (2001). Additive effects of intra-accumbens infusion of the cAMP-specific phosphodiesterase inhibitor, rolipram and cocaine on brain stimulation reward. Life Sci, 69(14): 1673–1682
CrossRef
Pubmed
Google scholar
|
[42] |
Kuroiwa M, Snyder G L, Shuto T, Fukuda A, Yanagawa Y, Benavides D R, Nairn A C, Bibb J A, Greengard P, Nishi A (2012). Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex. Psychopharmacology (Berl), 219(4): 1065–1079
CrossRef
Pubmed
Google scholar
|
[43] |
Lai M, Zhu H, Sun A, Zhuang D, Fu D, Chen W, Zhang H T, Zhou W (2014). The phosphodiesterase-4 inhibitor rolipram attenuates heroin-seeking behavior induced by cues or heroin priming in rats. Int J Neuropsychopharmacol, 17(9): 1397–1407
CrossRef
Pubmed
Google scholar
|
[44] |
Lakics V, Karran E H, Boess F G (2010). Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues. Neuropharmacology, 59(6): 367–374
CrossRef
Pubmed
Google scholar
|
[45] |
Lamontagne S, Meadows E, Luk P, Normandin D, Muise E, Boulet L, Pon D J, Robichaud A, Robertson G S, Metters K M, Nantel F (2001). Localization of phosphodiesterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkey. Brain Res, 920(1-2): 84–96
CrossRef
Pubmed
Google scholar
|
[46] |
Liddie S, Anderson K L, Paz A, Itzhak Y (2012). The effect of phosphodiesterase inhibitors on the extinction of cocaine-induced conditioned place preference in mice. J Psychopharmacol, 26(10): 1375–1382
CrossRef
Pubmed
Google scholar
|
[47] |
Lim Y W, Meyer N P, Shah A S, Budde M D, Stemper B D, Olsen C M (2015). Voluntary Alcohol Intake following Blast Exposure in a Rat Model of Mild Traumatic Brain Injury. PLoS ONE, 10(4): e0125130
CrossRef
Pubmed
Google scholar
|
[48] |
Liu X, Liu Y, Zhong P, Wilkinson B, Qi J, Olsen C M, Bayer K U, Liu Q S (2014). CaMKII activity in the ventral tegmental area gates cocaine-induced synaptic plasticity in the nucleus accumbens. Neuropsychopharmacology, 39(4): 989–999
CrossRef
Pubmed
Google scholar
|
[49] |
Logrip M L (2015). Phosphodiesterase regulation of alcohol drinking in rodents. Alcohol, 49(8): 795–802
CrossRef
Pubmed
Google scholar
|
[50] |
Logrip M L, Vendruscolo L F, Schlosburg J E, Koob G F, Zorrilla E P (2014). Phosphodiesterase 10A regulates alcohol and saccharin self-administration in rats. Neuropsychopharmacology, 39(7): 1722–1731
CrossRef
Pubmed
Google scholar
|
[51] |
Lu L, Grimm J W, Hope B T, Shaham Y (2004). Incubation of cocaine craving after withdrawal: a review of preclinical data. Neuropharmacology, 47(Suppl 1): 214–226
CrossRef
Pubmed
Google scholar
|
[52] |
Lugnier C (2006). Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol Ther, 109(3): 366–398
CrossRef
Pubmed
Google scholar
|
[53] |
MacKenzie S J, Houslay M D (2000). Action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of cAMP-response-element-binding protein (CREB) and p38 mitogen-activated protein (MAP) kinase in U937 monocytic cells. Biochem J, 347(Pt 2): 571–578
CrossRef
Pubmed
Google scholar
|
[54] |
Mamiya T, Noda Y, Ren X, Hamdy M, Furukawa S, Kameyama T, Yamada K, Nabeshima T (2001). Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor. Br J Pharmacol, 132(5): 1111–1117
CrossRef
Pubmed
Google scholar
|
[55] |
Mantsch J R, Baker D A, Funk D, Lê A D, Shaham Y (2016). Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress. Neuropsychopharmacology, 41(1): 335–356
CrossRef
Pubmed
Google scholar
|
[56] |
McGirr A, Lipina T V, Mun H S, Georgiou J, Al-Amri A H, Ng E, Zhai D, Elliott C, Cameron R T, Mullins J G, Liu F, Baillie G S, Clapcote S J, Roder J C (2016). Specific Inhibition of Phosphodiesterase-4B Results in Anxiolysis and Facilitates Memory Acquisition. Neuropsychopharmacology, 41(4): 1080–1092
CrossRef
Pubmed
Google scholar
|
[57] |
Mori F, Pérez-Torres S, De Caro R, Porzionato A, Macchi V, Beleta J, Gavaldà A, Palacios J M, Mengod G (2010). The human area postrema and other nuclei related to the emetic reflex express cAMP phosphodiesterases 4B and 4D. J Chem Neuroanat, 40(1): 36–42
CrossRef
Pubmed
Google scholar
|
[58] |
Mori T, Baba J, Ichimaru Y, Suzuki T (2000). Effects of rolipram, a selective inhibitor of phosphodiesterase 4, on hyperlocomotion induced by several abused drugs in mice. Jpn J Pharmacol, 83(2): 113–118
CrossRef
Pubmed
Google scholar
|
[59] |
Muelbl M J,Nawarawong N N, Clancy P T, Nettesheim C E, Lim Y W,Olsen C M (2016). Responses to drugs of abuse and non-drug rewards in leptin deficient ob/ob mice. Psychopharmacology (Berl),233(14):2799–2811
|
[60] |
Mulhall A M, Droege C A, Ernst N E, Panos R J, Zafar M A (2015). Phosphodiesterase 4 inhibitors for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs. Expert Opin Investig Drugs, 24(12): 1597–1611
CrossRef
Pubmed
Google scholar
|
[61] |
Muschamp J W, Carlezon W A Jr (2013). Roles of nucleus accumbens CREB and dynorphin in dysregulation of motivation. Cold Spring Harb Perspect Med, 3(2): a012005
CrossRef
Pubmed
Google scholar
|
[62] |
Naganuma K, Omura A, Maekawara N, Saitoh M, Ohkawa N, Kubota T, Nagumo H, Kodama T, Takemura M, Ohtsuka Y, Nakamura J, Tsujita R, Kawasaki K, Yokoi H, Kawanishi M (2009). Discovery of selective PDE4B inhibitors. Bioorg Med Chem Lett, 19(12): 3174–3176
CrossRef
Pubmed
Google scholar
|
[63] |
Negus S S, Miller L L (2014). Intracranial self-stimulation to evaluate abuse potential of drugs. Pharmacol Rev, 66(3): 869–917
CrossRef
Pubmed
Google scholar
|
[64] |
Nestler E J (2015). Reflections on: “A general role for adaptations in G-Proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res
Pubmed
|
[65] |
Nishi A, Kuroiwa M, Miller D B, O’Callaghan J P, Bateup H S, Shuto T, Sotogaku N, Fukuda T, Heintz N, Greengard P, Snyder G L (2008). Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum. J Neurosci, 28(42): 10460–10471
CrossRef
Pubmed
Google scholar
|
[66] |
Núñez C, González-Cuello A, Sánchez L, Vargas M L, Milanés M V, Laorden M L (2009). Effects of rolipram and diazepam on the adaptive changes induced by morphine withdrawal in the hypothalamic paraventricular nucleus. Eur J Pharmacol, 620(1-3): 1–8
CrossRef
Pubmed
Google scholar
|
[67] |
O’Donnell J M, Zhang H T (2004). Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4). Trends Pharmacol Sci, 25(3): 158–163
CrossRef
Pubmed
Google scholar
|
[68] |
Olsen C M, Childs D S, Stanwood G D, Winder D G (2010). Operant sensation seeking requires metabotropic glutamate receptor 5 (mGluR5). PLoS ONE, 5(11): e15085
CrossRef
Pubmed
Google scholar
|
[69] |
Olsen C M, Winder D G (2006). A method for single-session cocaine self-administration in the mouse. Psychopharmacology (Berl), 187(1): 13–21
CrossRef
Pubmed
Google scholar
|
[70] |
Page C P, Spina D (2012). Selective PDE inhibitors as novel treatments for respiratory diseases. Curr Opin Pharmacol, 12(3): 275–286
CrossRef
Pubmed
Google scholar
|
[71] |
Pan B, Hillard C J, Liu Q S (2008). D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling. J Neurosci, 28(52): 14018–14030
CrossRef
Pubmed
Google scholar
|
[72] |
Pan B, Hillard C J, Liu Q S (2008). Endocannabinoid signaling mediates cocaine-induced inhibitory synaptic plasticity in midbrain dopamine neurons. J Neurosci, 28(6): 1385–1397
CrossRef
Pubmed
Google scholar
|
[73] |
Pan B, Zhong P, Sun D, Liu Q S (2011). Extracellular signal-regulated kinase signaling in the ventral tegmental area mediates cocaine-induced synaptic plasticity and rewarding effects. J Neurosci, 31(31): 11244–11255
CrossRef
Pubmed
Google scholar
|
[74] |
Pérez-Cadahía B, Drobic B, Davie J R (2011). Activation and function of immediate-early genes in the nervous system. Biochem Cell Biol, 89(1): 61–73
Pubmed
|
[75] |
Pérez-Torres S, Miró X, Palacios J M, Cortés R, Puigdoménech P, Mengod G (2000). Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and[3H]rolipram binding autoradiography. Comparison with monkey and rat brain. J Chem Neuroanat, 20(3-4): 349–374
CrossRef
Pubmed
Google scholar
|
[76] |
Pierce R C, Kalivas P W (1997). A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev, 25(2): 192–216
CrossRef
Pubmed
Google scholar
|
[77] |
Richter W, Menniti F S, Zhang H T, Conti M (2013). PDE4 as a target for cognition enhancement. Expert Opin Ther Targets, 17(9): 1011–1027
CrossRef
Pubmed
Google scholar
|
[78] |
Robichaud A, Stamatiou P B, Jin S L, Lachance N, MacDonald D, Laliberté F, Liu S, Huang Z, Conti M, Chan C C (2002). Deletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis. J Clin Invest, 110(7): 1045–1052
CrossRef
Pubmed
Google scholar
|
[79] |
Robinson T E, Berridge K C (1993). The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev, 18(3): 247–291
CrossRef
Pubmed
Google scholar
|
[80] |
Robinson T E, Berridge K C (2008). Review. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci, 363(1507): 3137–3146
CrossRef
Pubmed
Google scholar
|
[81] |
Rodd Z A, Bell R L, Sable H J, Murphy J M, McBride W J (2004). Recent advances in animal models of alcohol craving and relapse. Pharmacol Biochem Behav, 79(3): 439–450
CrossRef
Pubmed
Google scholar
|
[82] |
Schroeder J A, Ruta J D, Gordon J S, Rodrigues A S, Foote C C (2012). The phosphodiesterase inhibitor isobutylmethylxanthine attenuates behavioral sensitization to cocaine. Behav Pharmacol, 23(3): 310–314
CrossRef
Pubmed
Google scholar
|
[83] |
Shaham Y, Shalev U, Lu L, De Wit H, Stewart J (2003). The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl), 168(1-2): 3–20
CrossRef
Pubmed
Google scholar
|
[84] |
Siuciak J A, McCarthy S A, Chapin D S, Martin A N (2008). Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme. Psychopharmacology (Berl), 197(1): 115–126
CrossRef
Pubmed
Google scholar
|
[85] |
Snider S E, Hendrick E S, Beardsley P M (2013). Glial cell modulators attenuate methamphetamine self-administration in the rat. Eur J Pharmacol, 701(1-3): 124–130
CrossRef
Pubmed
Google scholar
|
[86] |
Snider S E, Vunck S A, van den Oord E J, Adkins D E, McClay J L, Beardsley P M (2012). The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice. Eur J Pharmacol, 679(1-3): 75–80
CrossRef
Pubmed
Google scholar
|
[87] |
Stolerman I P, Childs E, Ford M M, Grant K A (2011). Role of training dose in drug discrimination: a review. Behav Pharmacol, 22(5-6): 415–429
CrossRef
Pubmed
Google scholar
|
[88] |
Sun A, Zhuang D, Zhu H, Lai M, Chen W, Liu H, Zhang F, Zhou W (2015). Decrease of phosphorylated CREB and ERK in nucleus accumbens is associated with the incubation of heroin seeking induced by cues after withdrawal. Neurosci Lett, 591: 166–170
CrossRef
Pubmed
Google scholar
|
[89] |
Thompson B E, Sachs B D, Kantak K M, Cherry J A (2004). The Type IV phosphodiesterase inhibitor rolipram interferes with drug-induced conditioned place preference but not immediate early gene induction in mice. Eur J Neurosci, 19(9): 2561–2568
CrossRef
Pubmed
Google scholar
|
[90] |
Thomsen M, Caine S B (2005). Chronic intravenous drug self-administration in rats and mice. Curr Protoc Neurosci, 32:9.20:9.20.1–9.20.40
CrossRef
Google scholar
|
[91] |
Todd T P, Vurbic D, Bouton M E (2014). Behavioral and neurobiological mechanisms of extinction in Pavlovian and instrumental learning. Neurobiol Learn Mem, 108: 52–64
CrossRef
Pubmed
Google scholar
|
[92] |
Tzschentke T M (2007). Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol, 12(3-4): 227–462
CrossRef
Pubmed
Google scholar
|
[93] |
Wang Z Z, Zhang Y, Zhang H T, Li Y F (2015). Phosphodiesterase: an interface connecting cognitive deficits to neuropsychiatric and neurodegenerative diseases. Curr Pharm Des, 21(3): 303–316
CrossRef
Pubmed
Google scholar
|
[94] |
Wen R T, Feng W Y, Liang J H, Zhang H T (2015). Role of phosphodiesterase 4-mediated cyclic AMP signaling in pharmacotherapy for substance dependence. Curr Pharm Des, 21(3): 355–364
CrossRef
Pubmed
Google scholar
|
[95] |
Wen R T, Zhang M, Qin W J, Liu Q, Wang W P, Lawrence A J, Zhang H T, Liang J H (2012). The phosphodiesterase-4 (PDE4) inhibitor rolipram decreases ethanol seeking and consumption in alcohol-preferring Fawn-Hooded rats. Alcohol Clin Exp Res, 36(12): 2157–2167
CrossRef
Pubmed
Google scholar
|
[96] |
Yan Y, Nitta A, Mizuno T, Nakajima A, Yamada K, Nabeshima T (2006). Discriminative-stimulus effects of methamphetamine and morphine in rats are attenuated by cAMP-related compounds. Behav Brain Res, 173(1): 39–46
CrossRef
Pubmed
Google scholar
|
[97] |
Young R (2009). Drug Discrimination. In: Buccafusco J J, editor. Source Methods of Behavior Analysis in Neuroscience. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis
|
[98] |
Zhang H T (2009). Cyclic AMP-specific phosphodiesterase-4 as a target for the development of antidepressant drugs. Curr Pharm Des, 15(14): 1688–1698
CrossRef
Pubmed
Google scholar
|
[99] |
Zhang H T, Huang Y, Masood A, Stolinski L R, Li Y, Zhang L, Dlaboga D, Jin S L, Conti M, O’Donnell J M (2008). Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B). Neuropsychopharmacology, 33(7): 1611–1623
CrossRef
Pubmed
Google scholar
|
[100] |
Zhong P, Wang W, Yu F, Nazari M, Liu X, Liu Q S (2012). Phosphodiesterase 4 inhibition impairs cocaine-induced inhibitory synaptic plasticity and conditioned place preference. Neuropsychopharmacology, 37(11): 2377–2387
|
/
〈 | 〉 |